AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33970290 — intervention group
Group type: EXPERIMENTAL
Intervention: SRX246
Number of subjects: 0
Study 33970290 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32459035 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.005% estriol vaginal gel
Number of subjects: 61
Study 32459035 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 33887341 — intervention group
Group type: EXPERIMENTAL
Intervention: Thin-strut biodegradable polymer sirolimus-eluting stents (BP-SES)
Number of subjects: 145
Study 33887341 — intervention group
Group type: COMPARATOR
Intervention: Durable polymer everolimus-eluting stents (DP-EES)
Number of subjects: 145
Study 33125166 — intervention group
Group type: EXPERIMENTAL
Intervention: External + Internal Facilitation (EF/IF)
Number of subjects: 43
Study 33125166 — intervention group
Group type: COMPARATOR
Intervention: External Facilitation (EF)
Number of subjects: 43
Study 33832035 — intervention group
Group type: EXPERIMENTAL
Intervention: Subpressure subgroup (after adhesives applied)
Number of subjects: 120
Study 33832035 — intervention group
Group type: COMPARATOR
Intervention: Normal pressure subgroup (after adhesives applied)
Number of subjects: 120
Study 33832035 — intervention group
Group type: EXPERIMENTAL
Intervention: Subpressure subgroup
Number of subjects: 120
Study 33308820 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression Garments (CG)
Number of subjects: 8
Study 33308820 — intervention group
Group type: COMPARATOR
Intervention: Control Garment (normal cloth)
Number of subjects: 8
Study 34818660 — intervention group
Group type: EXPERIMENTAL
Intervention: SPC counselling
Number of subjects: 80
Study 34818660 — intervention group
Group type: COMPARATOR
Intervention: Brochure with SPC counselling on demand
Number of subjects: 80
Study 35319669 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic group (GAtb) - 500 mg amoxicillin + 400 mg metronidazole
Number of subjects: 45
Study 35319669 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic group (GProb) - Lactobacillus reuteri
Number of subjects: 45
Study 35319669 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 45
Study 36478225 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 5988
Study 36478225 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5988
Study 33429767 — intervention group
Group type: EXPERIMENTAL
Intervention: Early path nursing
Number of subjects: 0
Study 33138740 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured play-based life-skills intervention (biweekly games led by a coach for 30 minutes)
Number of subjects: 1752
Study 33138740 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1752
Study 33053456 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten ingestion (0.5 or 2 g/d for 7 days)
Number of subjects: 30
Study 33053456 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for a total of 4 weeks)
Number of subjects: 30
Study 33053456 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline symptoms in NCGS patients
Number of subjects: 30
Study 33053456 — intervention group
Group type: EXPERIMENTAL
Intervention: Stool and urine GIPs
Number of subjects: 30
Study 33053456 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to gluten-free diet (GFD)
Number of subjects: 30
Study 33074291 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose erythropoietin
Number of subjects: 0
Study 33074291 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36044664 — intervention group
Group type: EXPERIMENTAL
Intervention: 22-week family-based lifestyle and psychoeducational intervention plus supervised exercise (exercise group, n = 59)
Number of subjects: 116
Study 36044664 — intervention group
Group type: COMPARATOR
Intervention: 22-week family-based lifestyle and psychoeducational intervention (control group, n = 57)
Number of subjects: 116
Study 36044664 — intervention group
Group type: EXPERIMENTAL
Intervention: Between-group analysis of IMAAT responders
Number of subjects: 116
Study 33444158 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention group
Number of subjects: 3232
Study 33444158 — intervention group
Group type: COMPARATOR
Intervention: Metformin group
Number of subjects: 3232
Study 33444158 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 3232
Study 32981043 — intervention group
Group type: EXPERIMENTAL
Intervention: GONB with bupivacaine 0.5% (3 mL each side)
Number of subjects: 99
Study 32981043 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide 10 mg IV
Number of subjects: 99
Study 32981043 — intervention group
Group type: EXPERIMENTAL
Intervention: GONB with bupivacaine
Number of subjects: 99
Study 32981043 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 99
Study 35345656 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA supplementation in the intervention group (Ig)
Number of subjects: 32
Study 35345656 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 32
Study 33619910 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal behavioral lifestyle intervention
Number of subjects: 217
Study 33619910 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 217
Study 34180437 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG-controlled FES system
Number of subjects: 29
Study 33871817 — intervention group
Group type: EXPERIMENTAL
Intervention: Givosiran (Givlaari)
Number of subjects: 0
Study 33871817 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36357806 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular depot medroxyprogesterone acetate (DMPA‐IM)
Number of subjects: 458
Study 36357806 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper intrauterine device (Cu‐IUD)
Number of subjects: 458
Study 36357806 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel (LNG) implant
Number of subjects: 458
Study 36357806 — intervention group
Group type: COMPARATOR
Intervention: DMPA‐IM
Number of subjects: 458
Study 33942167 — intervention group
Group type: EXPERIMENTAL
Intervention: NIPEC (Normothermic Intraperitoneal Chemotherapy)
Number of subjects: 74
Study 33942167 — intervention group
Group type: COMPARATOR
Intervention: Standardized cytoreductive surgery and perioperative chemotherapy
Number of subjects: 74
Study 32690749 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial 7 French access with Terumo Glidesheath Slender (Terumo, Japan)
Number of subjects: 388
Study 32690749 — intervention group
Group type: COMPARATOR
Intervention: Femoral 7 French access
Number of subjects: 388
Study 36106560 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-distancing writing task
Number of subjects: 859
Study 36106560 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-immersive writing task
Number of subjects: 859
Study 36106560 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 859
Study 33608139 — intervention group
Group type: COMPARATOR
Intervention: CAD + 0.2% NaF (CAD/NaF)
Number of subjects: 255
Study 33608139 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD + CPP-ACP (CAD/ACP)
Number of subjects: 255
Study 33608139 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD + Curodont™ Repair (CAD/P11-4)
Number of subjects: 255
Study 33608139 — intervention group
Group type: EXPERIMENTAL
Intervention: Sound dentin (SD)
Number of subjects: 255
Study 33608139 — intervention group
Group type: COMPARATOR
Intervention: CAD (Control)
Number of subjects: 255
Study 32377180 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral acupuncture at ST 38 on the nonpainful side
Number of subjects: 24
Study 32377180 — intervention group
Group type: COMPARATOR
Intervention: Ipsilateral acupuncture at ST 38 on the painful side
Number of subjects: 24
Study 36348313 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral therapy counseling (8 systematic desensitization sessions, 2-3 sessions per week)
Number of subjects: 46
Study 36348313 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 46
Study 36348313 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral therapy counseling
Number of subjects: 46
Study 33110070 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 outbreak in Wuhan
Number of subjects: 0
Study 34494903 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary balloon angioplasty
Number of subjects: 80
Study 34494903 — intervention group
Group type: COMPARATOR
Intervention: Hydrostatic dilatation
Number of subjects: 80
Study 33865577 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate rate of MR (MOD; 0.66 kg/d for 39 d, then 0.33 kg/d for 3 d)
Number of subjects: 48
Study 33865577 — intervention group
Group type: COMPARATOR
Intervention: Ad libitum rate of MR (ADLIB; offered twice daily for 35 d, 0.66 kg/d for 4 d, and 0.33 kg/d for 3 d)
Number of subjects: 48
Study 33865577 — intervention group
Group type: EXPERIMENTAL
Intervention: Step-up rate of MR (STEPUP; increased from 0.32 to 0.62 kg/d in first 12 d, 0.66 kg/d for 27 d, and 0.33 kg/d for 3 d)
Number of subjects: 48
Study 33831935 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone (200 mg orally 24-48 hours before misoprostol)
Number of subjects: 66
Study 33831935 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol (400 micrograms every 6 hours vaginally for women at 24 weeks of gestation or less, and 200 micrograms every 4 hours vaginally for women at 24 weeks of gestation or more)
Number of subjects: 66
Study 33831935 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone (200 mg)
Number of subjects: 66
Study 33831935 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol (control)
Number of subjects: 66
Study 35705934 — intervention group
Group type: EXPERIMENTAL
Intervention: Engagement with healthcare providers (HCPs)
Number of subjects: 41
Study 35705934 — intervention group
Group type: EXPERIMENTAL
Intervention: Internalized stigma
Number of subjects: 41
Study 33968867 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation group training based on problem-solving skills (4 sessions)
Number of subjects: 60
Study 33968867 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 32591326 — intervention group
Group type: EXPERIMENTAL
Intervention: TGA-guided training for pharmacists (three sessions over one year)
Number of subjects: 640
Study 32591326 — intervention group
Group type: COMPARATOR
Intervention: Pharmaceutical training program without a communication component
Number of subjects: 640
Study 32572446 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced skin hygiene intervention
Number of subjects: 86
Study 32572446 — intervention group
Group type: COMPARATOR
Intervention: Disposable N95 mask or half facepiece mask with P100 organic vapour cartridge
Number of subjects: 86
Study 32572446 — intervention group
Group type: COMPARATOR
Intervention: Normal skin hygiene
Number of subjects: 86
Study 35552673 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib (125 mg orally/day; 3/1 week schedule) and Fulvestrant (500 mg intramuscularly)
Number of subjects: 521
Study 35552673 — intervention group
Group type: COMPARATOR
Intervention: Placebo and Fulvestrant (500 mg intramuscularly)
Number of subjects: 521
Study 35552673 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib plus Fulvestrant
Number of subjects: 521
Study 35552673 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus Fulvestrant
Number of subjects: 521
Study 32370635 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflecting on important life lessons
Number of subjects: 202
Study 32370635 — intervention group
Group type: COMPARATOR
Intervention: Typical morning routine (Control)
Number of subjects: 202
Study 32248591 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin D supplementation (400 IU/d)
Number of subjects: 78
Study 32248591 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 35174850 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic Therapy in Care Homes Trial (PROTECT-CH)
Number of subjects: 0
Study 35174850 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 33189562 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of CDK4/6 inhibitors (CDK4/6i) beyond first disease progression (PD)
Number of subjects: 30
Study 33189562 — intervention group
Group type: COMPARATOR
Intervention: CDK4/6 inhibitors (CDK4/6i)
Number of subjects: 30
Study 32271268 — intervention group
Group type: EXPERIMENTAL
Intervention: Phacoemulsification in patients with cornea guttata
Number of subjects: 276362
Study 32271268 — intervention group
Group type: COMPARATOR
Intervention: Phacoemulsification in patients without cornea guttata
Number of subjects: 276362
Study 35807960 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-Informed Documentary
Number of subjects: 0
Study 35807960 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 0
Study 34180435 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etch adhesive system
Number of subjects: 60
Study 34180435 — intervention group
Group type: COMPARATOR
Intervention: Etch-and-rinse adhesive system
Number of subjects: 60
Study 35560470 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary nitrate supplements (140 ml of beetroot juice; 800 mg nitrate/day)
Number of subjects: 14
Study 35560470 — intervention group
Group type: COMPARATOR
Intervention: Placebo (140 ml of nitrate-depleted BRJ daily)
Number of subjects: 14
Study 34114199 — intervention group
Group type: EXPERIMENTAL
Intervention: One-incision procedure (Group A)
Number of subjects: 280
Study 34114199 — intervention group
Group type: COMPARATOR
Intervention: Two-incision procedure (Group B)
Number of subjects: 280
Study 32702276 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic tape (ET)
Number of subjects: 0
Study 36177369 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES device (n = 30)
Number of subjects: 60
Study 36177369 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 30)
Number of subjects: 60
Study 32070797 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 122
Study 32070797 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study 36293365 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Betula alba and Empetrum nigrum extracts
Number of subjects: 0
Study 33792252 — intervention group
Group type: EXPERIMENTAL
Intervention: Health technology interventions for Heart Failure management
Number of subjects: 0
Study 33792252 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-trial service improvement studies like OPTIMIZE-HF
Number of subjects: 0
Study 34591080 — intervention group
Group type: EXPERIMENTAL
Intervention: GAIN (geriatric assessment-driven intervention)
Number of subjects: 613
Study 34591080 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 613
Study 36394498 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance-Based Therapy (ABT) intervention, 15 virtual, 90-minute group sessions.
Number of subjects: 40
Study 36394498 — intervention group
Group type: COMPARATOR
Intervention: Enhanced care, 15 healthy lifestyle handouts, met virtually twice with a registered dietitian.
Number of subjects: 40
Study 33689702 — intervention group
Group type: EXPERIMENTAL
Intervention: CDK4/6 inhibitors (specific inhibitors not mentioned)
Number of subjects: 0
Study 32951763 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitter melon extract for 12 weeks
Number of subjects: 90
Study 32951763 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 36065041 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week reactive agility training program using light-based stimuli (Witty SEM light stimulus), 60-min training sessions twice a week
Number of subjects: 24
Study 36065041 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 24
Study 33676384 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 2 mg i.v. followed by standard general anesthesia with propofol, oxygen, nitrous oxide 60 %, isoflurane 1 MAC, and sufentanil 5-10 µg
Number of subjects: 27
Study 33676384 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 27
Study 33676384 — intervention group
Group type: EXPERIMENTAL
Intervention: End of surgery and end of anesthesia with closed eyes
Number of subjects: 27
Study 33676384 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-anesthesia (eyes opened)
Number of subjects: 27
Study 35289295 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin 50 mg/kg/d for 7 days
Number of subjects: 432
Study 35289295 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 432
Study 33727035 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-ARDS psychosocial impairment
Number of subjects: 0
Study 33727035 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-ARDS physical impairment with low psychosocial impairment
Number of subjects: 0
Study 33727035 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-ARDS physical impairment with high psychosocial impairment
Number of subjects: 0
Study 33727035 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-ARDS pain
Number of subjects: 0
Study 33727035 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-ARDS fatigue
Number of subjects: 0
Study 34009881 — intervention group
Group type: EXPERIMENTAL
Intervention: Elbow-Lock Chest Compression (ELCC)
Number of subjects: 34
Study 34009881 — intervention group
Group type: COMPARATOR
Intervention: Standard Chest Compression (SCC)
Number of subjects: 34
Study 34596303 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribbond+FBR
Number of subjects: 120
Study 34596303 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribbond+SDR+Filtek Z550
Number of subjects: 120
Study 34596303 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtek Z550
Number of subjects: 120
Study 34596303 — intervention group
Group type: EXPERIMENTAL
Intervention: FBR
Number of subjects: 120
Study 34596303 — intervention group
Group type: EXPERIMENTAL
Intervention: SDR+Filtek Z550
Number of subjects: 120
Study 34596303 — intervention group
Group type: EXPERIMENTAL
Intervention: EverX+Filtek Z550
Number of subjects: 120
Study 34596303 — intervention group
Group type: COMPARATOR
Intervention: Negative control
Number of subjects: 120
Study 34596303 — intervention group
Group type: COMPARATOR
Intervention: Positive control
Number of subjects: 120
Study 32543164 — intervention group
Group type: EXPERIMENTAL
Intervention: LINCOCIN®
Number of subjects: 24
Study 32543164 — intervention group
Group type: COMPARATOR
Intervention: AZITRO®
Number of subjects: 24
Study 35072922 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 0
Study 35072922 — intervention group
Group type: COMPARATOR
Intervention: Antihypertensive therapy
Number of subjects: 0
Study 33355637 — intervention group
Group type: EXPERIMENTAL
Intervention: DSAEK with donor cornea preservation time of 7 days or less
Number of subjects: 1090
Study 35303509 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT) delivered by the CyberKnife® system targeting resection margin one month after surgery; total dose of 35 Gy.
Number of subjects: 76
Study 35303509 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (SA) group; no specific dosage mentioned.
Number of subjects: 76
Study 33990652 — intervention group
Group type: EXPERIMENTAL
Intervention: ABP501
Number of subjects: 80
Study 33990652 — intervention group
Group type: EXPERIMENTAL
Intervention: SB5
Number of subjects: 80
Study 33990652 — intervention group
Group type: COMPARATOR
Intervention: ADA originator
Number of subjects: 80
Study 32653339 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed bio‐inspired cryptographic DNA system using Whale Optimization Algorithm (WOA)
Number of subjects: 0
Study 32653339 — intervention group
Group type: COMPARATOR
Intervention: Traditional cryptographic techniques
Number of subjects: 0
Study 616374539 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 50 mg twice daily
Number of subjects: 0
Study 616374539 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35606172 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 2364
Study 35606172 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 2364
Study 33161904 — intervention group
Group type: EXPERIMENTAL
Intervention: Blackcurrant purée with added sugars (BC)
Number of subjects: 26
Study 33161904 — intervention group
Group type: EXPERIMENTAL
Intervention: Product consisting of blackcurrant purée and fermented quinoa (BCP)
Number of subjects: 26
Study 33161904 — intervention group
Group type: COMPARATOR
Intervention: Reference product (SW)
Number of subjects: 26
Study 33047417 — intervention group
Group type: EXPERIMENTAL
Intervention: Copayment elimination for cardioprotective medications
Number of subjects: 53
Study 33047417 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored self-management support programme
Number of subjects: 53
Study 33047417 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (copayment elimination and tailored self-management support)
Number of subjects: 53
Study 34529944 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive monitoring
Number of subjects: 2708
Study 34529944 — intervention group
Group type: COMPARATOR
Intervention: Limited monitoring
Number of subjects: 2708
Study 32146337 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized single-session interventions (SSIs) based on behavioral activation, gratitude, and growth mindset exercises
Number of subjects: 0
Study 35263746 — intervention group
Group type: EXPERIMENTAL
Intervention: EMiC®2‐CVVHD
Number of subjects: 20
Study 35263746 — intervention group
Group type: COMPARATOR
Intervention: AV1000S®‐CVVHDF
Number of subjects: 20
Study 35263746 — intervention group
Group type: EXPERIMENTAL
Intervention: Both modalities
Number of subjects: 20
Study 35263746 — intervention group
Group type: EXPERIMENTAL
Intervention: EMiC®2
Number of subjects: 20
Study 35263746 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 20
Study 36224090 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Motivational Interviewing (BMI)
Number of subjects: 60
Study 36224090 — intervention group
Group type: COMPARATOR
Intervention: Traditional Oral Hygiene Instruction (OHI)
Number of subjects: 60